Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 15, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 18, 2026
OfficerIndirect holdingTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001673232-26-000013
Filed / recorded
Mar 18, 2026, 1:10 AM UTC
Added to OQRO
Oct 6, 2026, 9:34 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
UNITED THERAPEUTICS Corp
Issuer CIK
1082554
Ticker
UTHR
Reporting person
Michael Benkowitz
Relationship
Officer
Officer title
PRESIDENT AND COO
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Mar 15, 2026
Transaction code
F
Shares / units
6,869
Price per share
$536.12
Acquired / disposed
Disposed (D)
Shares owned after
19,046
Ownership form
Indirect — by Trust
Amendment
No
Footnotes from the filing
Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units.
Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.